貨號(hào)
產(chǎn)品規(guī)格
售價(jià)
備注
BN41132R-100ul
100ul
￥2360.00
交叉反應(yīng)：Human 推薦應(yīng)用：WB,IHC-P,ICC
產(chǎn)品描述
| 英文名稱 | SMARCA4 |
| 中文名稱 | 抑癌基因SNF2β抗體 |
| 別 名 | BRG1; ATP dependent helicase SMARCA4; BAF 190; BAF190; BAF190A; Brahma protein homolog 1; Brahma protein like 1; BRG 1; BRG 1 protein; BRG1; BRG1 associated factor 190A; BRG1 protein; BRM/SWI2 related gene 1; Global transcription activator homologous sequence; Homeotic gene regulator; hSNF2b; Mitotic growth and transcription activator; Nuclear protein GRB1; Probable global transcription activator SNF2L4; Protein brahma homolog 1; Protein BRG1; SMARC A4; SMARCA 4; SMARCA4; SNF 2; SNF 2B; SNF2;;brahma-related gene 1; SNF2 beta; SNF2 like 4; SNF2B; SNF2beta; SNF2L4; SNF2LB; SWI 2; SWI/SNF related matrix associated actin dependent regulator of chromatin subfamily A member 4; SWI2; Transcription activator BRG1. |
| 研究領(lǐng)域 | 腫瘤 免疫學(xué) 細(xì)胞凋亡 轉(zhuǎn)錄調(diào)節(jié)因子 |
| 抗體來(lái)源 | Rabbit |
| 克隆類型 | Polyclonal |
| 交叉反應(yīng) | Human, |
| 產(chǎn)品應(yīng)用 | WB=1:500-2000 IHC-P=1:50-100 ICC=1:100 （石蠟切片需做抗原修復(fù)） not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 分 子 量 | 181kDa |
| 細(xì)胞定位 | 細(xì)胞核 |
| 性 狀 | Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human SMARCA4:30-130/1647 |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 儲(chǔ) 存 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| 保存條件 | Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. |
| PubMed | PubMed |
| 產(chǎn)品介紹 | The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Alternatively spliced transcripts have been found for this gene, but their full-length natures have not been determined. Function: Transcriptional coactivator cooperating with nuclear hormone receptors to potentiate transcriptional activation. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a post-mitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. Subunit: Belongs to the SNF2/RAD54 helicase family. Contains 1 bromo domain. Contains 1 helicase ATP-binding domain. Contains 1 helicase C-terminal domain. Contains 1 HSA domain. Tissue Specificity: Colocalizes with ZEB1 in E-cadherin-negative cells from established lines, and stroma of normal colon as well as in de-differentiated epithelial cells at the invasion front of colorectal carcinomas (at protein level). DISEASE: Defects in SMARCA4 are the cause of rhabdoid tumor predisposition syndrome type 2 (RTPS2). RTPS2 is a familial cancer syndrome predisposing to renal or extrarenal malignant rhabdoid tumors and to a variety of tumors of the central nervous system, including choroid plexus carcinoma, medulloblastoma, and central primitive neuroectodermal tumors. Rhabdoid tumors are the most aggressive and lethal malignancies occurring in early childhood. SWISS: P51532 Gene ID: 6597 Database links: Entrez Gene: 6597 Human Entrez Gene: 20586 Mouse Omim: 603254 Human SwissProt: P51532 Human SwissProt: Q3TKT4 Mouse Unigene: 327527 Human Unigene: 286593 Mouse Unigene: 23417 Rat Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 轉(zhuǎn)錄調(diào)節(jié)因子（Transcriptin Regulators） SMARCA4是一種新的抑癌基因，已在許多腫瘤的研究中發(fā)現(xiàn)它是一種重要的抑癌基因，很多腫瘤的發(fā)生與其功能失活或出現(xiàn)基因突變、缺失相關(guān)聯(lián)。 |
在線咨詢
English
